Steven F. Palter — Endo Lab

review 2011

·doi:10.1017/cbo9780511734755

Human Assisted Reproductive Technology: Future Trends in Laboratory and Clinical Practice offers a collection of concise, practical review articles on cutting-edge topics within reproductive medicine. Each article presents a balanced view o…

2005

High Rates of Endometriosis in Patients With Intrauterine Synechiae (Asherman’s Syndrome)

·doi:10.1016/j.fertnstert.2005.07.1239

2002

Microlaparoscopy for Infertility in the Office

·doi:10.1007/978-3-642-87690-5_13

2001

Interleukin-8 in the Human Fallopian Tube

·doi:10.1210/jc.86.6.2660

The human fallopian tube is a dynamic structure that undergoes cyclic variation in its functional epithelium. This epithelium contains both secretory and ciliated cells. The mechanisms regulating the growth and function of the tubal epithel…

other 1999

Office microlaparoscopy under local anesthesia

Obstetrics and Gynecology Clinics of North America ·doi:10.1016/s0889-8545(05)70061-9

Office laparoscopy under local anesthesia is especially suited to meet the current pressures of quality versus cost in an era of managed care. It is likely that this technique will soon become a major part of the practicing gynecologist's d…

other 1996

Office microlaparoscopy under local anesthesia for chronic pelvic pain

The Journal of the American Association of Gynecologic Laparoscopists ·doi:10.1016/s1074-3804(96)80064-8

STUDY OBJECTIVE: To investigate the utility, tolerance, and costs associated with a program of office laparoscopy under local anesthesia using fiberoptic microlaparoscopes (<2 mm) and accessory instrumentation (<2 mm) for the evaluation of …

nonrandomized-trial 1991

Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes

Fertility and sterility

OBJECTIVE: To assess whether the therapeutic effect of danazol on premenstrual syndromes (PMS) is associated with suppression of ovulation. DESIGN: After 1 month on placebo, we administered 200 mg/d of danazol for 90 days to 24 women with …

nonrandomized-trial 1991

Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes

·doi:10.1016/s0015-0282(16)54718-9

ObjectiveTo assess whether the therapeutic effect of danazol on premenstrual syndromes (PMS) is associated with suppression of ovulation.DesignAfter 1 month on placebo, we administered 200 mg/d of danazol for 90 days to 24 women with dyspho…